Sionna Stock 144% This Year: Is the Biotech a Buy Now?
Sionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
Understand when to choose long term vs short term investments. Make strategic decisions that align with your goals.
27,010 articlesSionna Therapeutics has surged 144% over the past year, drawing attention from growth-minded investors. This article ...
AI promises efficiency, but real payback is slow for families and small firms. Analysts say it’s hard from because bu...
Across Latin America, a new wave of fintechs is defying expectations. This article dives into three standout players,...
LISC CEO Michael Pugh warns that housing costs outpace wages are widening the affordability gap. The charity-finance ...
Lucid has built a reputation for rapid delivery gains, echoing early EV winners. This deep dive explains why the stoc...
Netflix’s ad-supported tier is gaining traction and subscribers are rising, even as the broader market spurs a debate...
NVIDIA revealed a $500 million strategic deal with CORNING to bolster optical connectivity for AI data centers, spark...
Institutional interest could accelerate on chain liquidity and push UNI higher. This article explores the pathways, r...
AI demand is broadening from chipmakers to the hardware backbone that powers deployments, a shift that could lift inf...
Alphabet blew past expectations with a robust earnings beat and a cloud backlog that leapt to $460 billion, signaling...
Palantir just beat earnings, yet its stock fell in after-hours trading as traders priced in slower growth and macro h...
A Manhattan federal judge sentenced a New York City teenager to 66 months in prison after he admitted to igniting a f...